BridgeBio Pharma, Inc. (FRA:2CL)

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $120.70M USD in the quarter ending September 30, 2025, with 4,318.01% growth. This brings the company's revenue in the last twelve months to $353.78M, up 62.46% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.

• Revenue (ttm): $353.78M
• Revenue Growth: +62.46%
• P/S Ratio: 41.57
• Revenue / Employee: $484.63K
• Employees: 730
• Market Cap: 12.53B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	221.90M	212.60M	2,285.27%
Dec 31, 2023	9.30M	-68.35M	-88.02%
Dec 31, 2022	77.65M	7.93M	11.38%
Dec 31, 2021	69.72M	61.47M	745.14%
Dec 31, 2020	8.25M	-32.31M	-79.66%
Dec 31, 2019	40.56M	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-